Judith Sinzig

Prof. Judith Sinzig


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2008 in Child and Adolescent Psychiatry and Mental Health
Verified
Journal Article
Open access
PDF file
JSJudith Sinzig
Judith Sinzig
DMDagmar Morsch
Dagmar Morsch
NBNicole Bruning
Nicole Bruning
MSMartin H Schmidt
Martin H Schmidt
GLGerd Lehmkuhl
Gerd Lehmkuhl
Recent studies have not paid a great deal of attention to comorbid attention-deficit/hyperactivity disorder (ADHD) symptoms in autistic children even though it is well known that almost half of children with autism spectrum disorder (ASD) suffer from hyperactivity, inattention and impulsivity. The goal of this study was to evaluate and compare executive functioning (EF) profiles in children with ADHD and in children with ASD with and without comorbid ADHD.

20 April 2009 in Journal of Attention Disorders
Verified
Journal Article
Closed access
JSJudith Sinzig
Judith Sinzig
DWDaniel Walter
Daniel Walter
MDManfred Doepfner
Manfred Doepfner
Objective: This study aims to evaluate ADHD-like symptoms in children with autism spectrum disorder (ASD) based on single-item analysis, as well as the comparison of two ASD subsamples of children with ADHD (ASD+) and without ADHD (ASD-). Methods: Participants are 83 children with ASD. Dimensional and categorical aspects of ADHD are evaluated using a diagnostic symptom checklist according to DSM-IV. Results: Of the sample, 53% fulfill DSM-IV criteria for ADHD. The comparison of the ASD+ and the ASD- samples reveals differences in age and IQ. Correlations of ADHD and PDD show significant results for symptoms of hyperactivity with impairment in communication and for inattention with stereotyped behavior. Item profiles of ADHD symptoms in the ASD+ sample are similar to those in a pure ADHD sample. Conclusion: The results of our study reveal a high phenotypical overlap between ASD and ADHD. The two identified subtypes, inattentive-stereotyped and hyperactive-communication impaired, reflect the DSM classification and may theoretically be a sign of two different neurochemical pathways, a dopaminergic and a serotonergic. (J. of Att. Dis. 2009; 13(2) 117-126)

24 September 2007 in European Child & Adolescent Psychiatry
Verified
Journal Article
Closed access
PDF file
JSJudith Sinzig
Judith Sinzig
DMDagmar Morsch
Dagmar Morsch
GLGerd Lehmkuhl
Gerd Lehmkuhl

27 April 2015 in Autism
Verified
Journal Article
Closed access
ESErica Salomone
Erica Salomone
ŠBŠtěpánka Beranová
Štěpánka Beranová
FBFrédérique Bonnet-Brilhault
Frédérique Bonnet-Brilhault
MLMarlene Briciet Lauritsen
Marlene Briciet Lauritsen
MBMagdalena Budisteanu
Magdalena Budisteanu
TCTony Charman
Tony Charman
Little is known about use of early interventions for autism spectrum disorder in Europe. Parents of children with autism spectrum disorder aged 7 years or younger (N = 1680) were recruited through parent organisations in 18 European countries and completed an online survey about the interventions their child received. There was considerable variation in use of interventions, and in some countries more than 20% of children received no intervention at all. The most frequently reported interventions were speech and language therapy (64%) and behavioural, developmental and relationship-based interventions (55%). In some parts of Europe, use of behavioural, developmental and relationship-based interventions was associated with higher parental educational level and time passed since diagnosis, rather than with child characteristics. These findings highlight the need to monitor use of intervention for children with autism spectrum disorder in Europe in order to contrast inequalities.

20 November 2012 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
IJI Jarick
I Jarick
AVA-L Volckmar
A-L Volckmar
CPC Pütter
C Pütter
SPS Pechlivanis
S Pechlivanis
TNT T Nguyen
T T Nguyen
AHA Hinney
A Hinney
Attention-deficit/hyperactivity disorder (ADHD) is a common, highly heritable neurodevelopmental disorder. Genetic loci have not yet been identified by genome-wide association studies. Rare copy number variations (CNVs), such as chromosomal deletions or duplications, have been implicated in ADHD and other neurodevelopmental disorders. To identify rare (frequency 1%) CNVs that increase the risk of ADHD, we performed a whole-genome CNV analysis based on 489 young ADHD patients and 1285 adult population-based controls and identified one significantly associated CNV region. In tests for a global burden of large (>500 kb) rare CNVs, we observed a nonsignificant (P=0.271) 1.126-fold enriched rate of subjects carrying at least one such CNV in the group of ADHD cases. Locus-specific tests of association were used to assess if there were more rare CNVs in cases compared with controls. Detected CNVs, which were significantly enriched in the ADHD group, were validated by quantitative (q)PCR. Findings were replicated in an independent sample of 386 young patients with ADHD and 781 young population-based healthy controls. We identified rare CNVs within the parkinson protein 2 gene (PARK2) with a significantly higher prevalence in ADHD patients than in controls (P=2.8 × 10−4 after empirical correction for genome-wide testing). In total, the PARK2 locus (chr 6: 162 659 756–162 767 019) harboured three deletions and nine duplications in the ADHD patients and two deletions and two duplications in the controls. By qPCR analysis, we validated 11 of the 12 CNVs in ADHD patients (P=1.2 × 10−3 after empirical correction for genome-wide testing). In the replication sample, CNVs at the PARK2 locus were found in four additional ADHD patients and one additional control (P=4.3 × 10−2). Our results suggest that copy number variants at the PARK2 locus contribute to the genetic susceptibility of ADHD. Mutations and CNVs in PARK2 are known to be associated with Parkinson disease.

19 October 2011 in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
Verified
Journal Article
Closed access
PDF file
AHAnke Hinney
Anke Hinney
ASAndré Scherag
André Scherag
IJIvonne Jarick
Ivonne Jarick
ÖAÖzgür Albayrak
Özgür Albayrak
CPCarolin Pütter
Carolin Pütter
PSPsychiatric GWAS Consortium: ADHD subgroup
Psychiatric GWAS Consortium: ADHD subgroup